Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and tolerability of chondroitin sulfate 1000 mg twice daily in symptomatic knee osteoarthritis
2009-014516-35Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Sep 2009
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of chondroitin sulfate in knee osteoarthritis (OA) (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Pain responder rate at 6 months and Function responder rate at 6 months. Started Sep 2009; status: completed.
02
Drugs
chondroitin sulfate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-014516-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014516-35.